Addition of anti-HGF to M2-CM abolished the activities of M2-CM on sorafenib, suggesting that HGF in M2-CM play the predominant role in hepatoma resistance to sorafenib conferred by M2 macrophages via sustaining tumour growth and metastasis. Here, HGF is linked to neoplasm.